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Introduction
The mammalian endosomal system consists of a heterogeneous
set of compartments, including early endosomes, recycling
endosomes, late endosomes and lysosomes (Mellman, 1996).
Endocytic pathways function not only to internalize
extracellular components but are also involved in signal-
transduction pathways (Di Fiore and De Camilli, 2001;
McPherson et al., 2001). A major family of second messengers
are the phosphoinositides, membrane lipids that regulate a
wide variety of cellular processes (Rameh and Cantley, 1999;
Czech, 2000). Phosphoinositides are localized to discrete
regions within membranes and their synthesis and turnover is
highly regulated. The 3-phosphorylated phosphoinositides in
particular, regulate endocytic membrane trafficking, signal
transduction and cytoskeletal organization by interacting with
lipid binding domains of a variety of effectors (Sato et al.,
2001; Simonsen et al., 2001; Vanhaesebroeck et al., 2001). A
number of conserved protein domains have now been identified
which bind specifically to phosphoinositides, and these
domains act to recruit their host protein to specific membrane
compartments/domains via interactions with these membrane
lipids (Lemmon, 2003).
Sorting nexins (SNXs) have emerged as a large and diverse
family of hydrophilic cytoplasmic and membrane-associated
proteins considered to be involved in endocytosis (Teasdale et
al., 2001; Worby and Dixon, 2002). The hallmark of the SNX
family of ~24 members is the presence of a modestly conserved
Phox (PX) domain, a sequence of 70-120 residues that has been
shown to bind various phosphoinositides (Xu et al., 2001b;
Worby and Dixon, 2002). PX domains are present in many
yeast/mammalian membrane and vesicle-associated proteins
involved in a variety of cell functions (Ponting, 1996; Schultz
et al., 2000). Proteins can associate intimately and specifically
to membrane compartments through their PX domain, by
binding phosphoinositide lipids present in the membrane
(Wishart et al., 2001). In most cases studied so far PX domains
can bind the endosomal lipid phosphatidylinositol 3-
phosphate, PtdIns(3)P (Xu et al., 2001b; Yu and Lemmon,
2001; Lemmon, 2003).
From our studies based on BLAST searches and
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Sorting nexins are a large family of proteins that contain
the phosphoinositide-binding Phox homology (PX) domain.
A number of sorting nexins are known to bind to
PtdIns(3)P, which mediates their localization to
membranes of the endocytic pathway. We show here that
sorting nexin 5 (SNX5) can be recruited to two distinct
membrane compartments. In non-stimulated cells, the
PX domain was independently targeted to endosomal
structures and colocalized with full-length SNX5. The
membrane binding of the PX domain was inhibited by
the PI 3-kinase inhibitor, wortmannin. Although SNX5
colocalized with a fluid-phase marker and was found
predominantly within a PtdIns(3)P-rich endosomal
domain, very little colocalization was observed between
SNX5 and the PtdIns(3)P-binding protein, EEA1. Using
liposome-based binding assays, we have shown that the PX
domain of SNX5 interacts not only with PtdIns(3)P but also
with PtdIns(3,4)P2. In response to EGF stimulation, either
the SNX5-PX domain or full-length SNX5 was rapidly
recruited to the plasma membrane. The localization of
SNX1, which does not bind PtdIns(3,4)P2, was unaffected
by EGF signalling. Therefore, SNX5 is localized to a
subdomain of the early endosome distinct from EEA1 and,
following EGF stimulation and elevation of PtdIns(3,4)P2,
is also transiently recruited to the plasma membrane.
These results indicate that SNX5 may have functions not
only associated with endosomal sorting but also with the
phosphoinositide-signalling pathway.
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phylogenetic analysis, it is clear that the PX domains of SNXs
represent a distinct subgroup of the PX superfamily (Teasdale
et al., 2001). Therefore, the PX domains of SNX proteins
(SNX-PX) may have evolved unique characteristics/functions
compared with other PX domains. Within the SNX family, we
identified sub-groups based on the sequence similarity of the
SNX-PX domain and the overall domain structure of each
protein. The members of one sub-group, which includes human
SNX1, SNX2, SNX4, SNX5 and SNX6 and the yeast Vps5p
and YJL036W, all contain coiled-coil regions within their large
C-terminal domains, and are found distributed in both
membrane and cytosolic fractions, typical of hydrophilic
peripheral membrane proteins (Teasdale et al., 2001; Worby
and Dixon, 2002).
Members of the SNX family have been shown to have a role
in protein sorting within the endosomal pathway (Worby and
Dixon, 2002). In particular, a number of SNXs interact with
various membrane receptors (Haft et al., 1998; Parks et al.,
2001). Significantly, SNX1, SNX2 and Vps5p have been
identified to be part of a membrane-associated complex,
termed the retromer, which contains Vps26p, Vps29p and
Vps35p (Seaman et al., 1998; Haft et al., 2000). First identified
in yeast and now in mammalian cells, the retromer is
considered to function as a membrane coat complex for
vesicular transport in the endocytic pathway (Nothwehr et al.,
2000). The analysis of mice lacking SNX1 and SNX2 has
confirmed that SNXs perform essential functions in mammals
(Schwarz et al., 2002).
As phosphoinositides are known to play a key role in the
regulation of endosomal traffic (Simonsen et al., 2001), the
lipid binding properties of the SNX-PX domains are likely to
be fundamental for understanding their function. Early
endosomes are enriched for PtdIns(3)P (Gillooly et al., 2000),
therefore the phosphoinositide binding properties of the PX
domain are likely to partially account for the endosomal
localization of sorting nexins of mammals and yeast.
Nonetheless, it is clear that not all PtdIns(3)P binding proteins
are localized to the same membrane domain and furthermore,
it is possible that different SNXs operate in different classes of
endosomes (Hettema et al., 2003). Significantly recent studies
have shown that the PX domain of SNX1 binds with a similar
affinity to both PtdIns(3)P and PtdIns(3,5)P2, a specificity
which distinguishes this SNX-PX domain from other PX
domains that have been characterized (Cozier et al., 2002) and
from the PtdIns(3)P binding FYVE domain of the early
endosomal protein, EEA1 (Stenmark et al., 2002). The latter
study of SNX1 also demonstrated the importance of the PX
domain in the membrane binding property of SNX1 and the
ability of SNX1 to regulate EGF receptor degradation (Cozier
et al., 2002). In view of this finding, a highly relevant issue is
whether the PX domains of other SNX molecules may have
different phosphoinositide binding specificities that could
target their host protein to distinct subcellular compartments or
domains and/or allow their regulation by phosphoinositides
other than PtdIns(3)P. This possibility is particularly pertinent
in view of the fact that the sequence similarity between the
SNX-PX domains is only modest (50% similarity) (Teasdale
et al., 2001).
In view of the number of SNXs, it is possible that they have
a range of functions, unified by their ability to interact with
phosphoinositide intermediates. More information is clearly
required on the precise phosphatidylinositol binding
specificity of the PX domains of the different SNX molecules,
and their relative intracellular localization. Here we have
analysed the phosphoinositide binding specificity and
localization of another member of the SNX1-subfamily,
namely SNX5, in detail. Compared with SNX1-4, SNX5
contains an insert in its PX domain (Teasdale et al., 2001;
Worby and Dixon, 2002) and therefore may have subtle
differences in its phosphoinositide binding specificity that
could impart distinct functional properties to SNX5. Indeed,
here we show that the PX domain of SNX5 can bind
PtdIns(3)P as well as PtdIns(3,4)P2, a specificity that differs
from the PX domains of other SNXs characterized.
Furthermore, the ability to bind these two phosphoinositides
is consistent with a PX domain-dependent association of
SNX5 with endosomes in unstimulated cells, and the
subsequent movement of SNX5 to the plasma membrane
following EGF stimulation and elevation of PtdIns(3,4)P2. As
these results indicate that localization of SNX5 is responsive
to EGF signalling, the family of sorting nexins may have
broader functions than originally envisaged.
Materials and Methods
Antibodies
Human antibody against early endosome autoantigen 1 (EEA1) was
a kind gift from J. Callaghan (University of Melbourne). Monoclonal
antibodies to light and heavy chain clathrin and EEA1 were obtained
from BD Transduction Laboratories (Australia), and to human Lamp-
1 (CD107a) and SNX1 were obtained from Pharmingen International
(San Jose, CA, USA). Monoclonal antibodies to the human transferrin
receptor (OKT9) (Schneider et al., 1982) and the human epidermal
growth factor receptor (Gill et al., 1984) were purified from
hydridoma supernatants. Sheep anti-mouse Ig-FITC conjugate was
from Silenus Laboratories (Melbourne, Victoria, Australia), and goat
anti-mouse IgG-Alexa568, goat anti-human IgG-Alexa568, goat anti-
rabbit-Alexa568 and Texas Red dextran conjugates were purchased
from Molecular Probes (Eugene, Oregon, USA). Epitope-tagged
proteins were detected with monoclonal antibody anti-FLAG (M2)
purchased from Sigma (Castle Hill, NSW, Australia) and monoclonal
anti-GFP from Roche Molecular Biochemicals (Indianapolis, USA).
Horseradish peroxidase-conjugated anti-mouse Ig was obtained from
DAKO (Carpinteria, CA).
DNA constructs
Green fluorescent protein (GFP) constructs used are described
(Teasdale et al., 2001). Glutathione S-transferase (GST) fusion protein
was constructed using pGEX-6P-3 (Pharmacia). GST-SNX5PX fusion
protein was generated by subcloning the BamHI/BglII fragment from
pEGFP-SNX5PX construct directly into the BamHI site of pGEX-6P-
3. The construct GST-HrsFYVE encoding the FYVE domain of Hrs
corresponding to residues 147-223 (Komada and Soriano, 1999)
inserted at the C-terminus of GST in pGEX-6P-3 was provided by
Haydyn Mertons (Department of Biochemistry and Molecular
Biology, The University of Melbourne). GFP-FYVEEEA1 encodes the
FYVE domain of EEA1, corresponding to residues 1252-1411, cloned
into pEGFP (Hunyady et al., 2002) and was generously supplied by
Tamas Balla (NIH, Bethesda).
Cell culture and transfection
HeLa cells were maintained in Dulbecco’s modified Eagle’s medium
with 10% (v/v) foetal bovine serum, 100 units/ml penicillin, 100
µg/ml streptomycin and 2 mM L-glutamine in a humidified
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air/atmosphere (10% CO2) at 37°C. Cells were transiently
transfected with 1 µg plasmid DNA per well of a 12-well dish using
Fugene 6 transfection Reagent (Boehringer Mannheim, Germany)
according to the manufacturer’s instructions. The generation of the
Flp-InTM-HEK293 cell line expressing GFP-SNX5 was performed
as follows. The entire GFP-SNX5FL coding region was subcloned
from pEGFP-C1-GFP-SNX5FL (Teasdale et al., 2001) into
pcDNA5/FRT (Invitrogen) to generate pcDNA5/FRT-GFP-SNX5FL.
Flp-InTM-293 cells were maintained in culture containing 100 µg/ml
Zeocin. pcDNA5/FRT-GFP-SNX5FL and the Flp recombinase
expression vector, pOG44, were co-transfected at a 1:9 ratio into
70% confluent cells using the LF2000 system (Invitrogen). 24 hours
after transfection, the cells were washed with PBS and cultured for
another 24 hours in fresh media. Cells were again washed in PBS
as before and then cultured in media containing 50 µg/ml
hygromycin B.
Immunofluorescence
12 hours after transfection, cell monolayers were washed twice with
PBS and processed for immunofluorescence as described previously
(Kjer-Nielsen et al., 1999). Cells were incubated with the primary
antibody for 45 minutes at room temperature, washed three times with
PBS and incubated with the appropriate secondary antibody for 30
minutes at room temperature. Cells were examined by confocal
microscopy using the Bio-Rad MRC-1024 imaging system and
Lasersharp 3.1 software. For dual labelling, images were collected
independently to ensure there was no spill-over of fluorescence
between channels. For quantitative analysis, at least 100 transfected
cells were scored.
Wortmannin treatment
HeLa cells were transfected with GFP-SNX5PX and 12 hours later
cells were serum starved for 3 hours at 37°C. Serum-starved
transfected HeLa cells, or stably transfected HEK293 cells were
incubated at 37°C in the presence or absence of 100 nM wortmannin
(Calbiochem, USA) for the indicated times. Following treatment, cells
were washed three times in PBS, fixed and processed for
immunofluorescence.
Fluid-phase uptake of dextran
Cell monolayers were incubated with unlabeled dextran (5 mg/ml) (10
kDa, Amersham) in serum-free DMEM, for 15 minutes at 37°C,
washed in PBS, then incubated with 100-200 µg/ml Texas Red
dextran, in serum-free DMEM, for 15 minutes either on ice or at 37°C.
After the incubation, monolayers were immediately washed twice
with ice-cold PBS then fixed in 4% paraformaldehyde (PFA) for 15
minutes and washed in PBS.
EGF stimulation
Cell monolayers were serum starved for 3 hours and stimulated with
20-100 ng/ml human EGF (Gibco, California), in serum-free medium
for 0-30 minutes at 37°C. Cells were washed in PBS and fixed in 4%
PFA.
Immunoprecipitation experiments
HeLa cells, co-transfected with GFP-SNX5PX and FLAG-SNX5FL,
were harvested 12 hours after transfection and resuspended in lysis
buffer (1% Nonidet P-40 in PBS) containing a protease inhibitor
cocktail (Roche Diagnostics, Germany) for 30 minutes at 4°C.
Extracts were centrifuged at 14,000 g for 20 minutes at 4°C to remove
insoluble debris. Aliquots (0.5 ml) of the supernatant were treated
with 100 µl of 20% (w/v) protein G-Sepharose beads (Amersham
Biosciences, Sweden) for 30 minutes and after removal of the beads,
the supernatant was incubated with 2 µg anti-GFP or anti-FLAG
antibody for 4 hours at 4°C with gentle agitation, followed by the
addition of protein G-Sepharose beads for 30 minutes. Protein G-
Sepharose was washed three times in lysis buffer and twice in PBS.
Bound proteins were eluted by boiling the beads in SDS-PAGE
loading buffer.
Immunoblotting
Proteins were resolved on 10% polyacrylamide gels in the presence
of SDS and transferred onto PVDF membranes (Immobilon-P,
Millipore) according to the manufacturer’s instructions and
immunoblotting performed as described (Gleeson et al., 1996).
Immunoprecipitated proteins were visualized with either anti-GFP or
anti-FLAG monoclonal antibodies followed by horseradish
peroxidase-conjugated anti-mouse secondary antibody. Antibodies
were diluted in of PBS containing 0.05% Tween-20. Blots were
developed with enhanced luminol reagent (NEN, Boston, MA, USA)
and visualized by chemiluminescence on Biomax MR film (Eastman
Kodak Co.).
Protein expression and purification
Bacterial expression of GST-SNX5PX and GST-Hrs fusion protein was
induced by addition of 0.1 mM isopropyl β-D-thiogalactoside (IPTG)
to recombinant DH5α cultures for 3 hours at 30°C. Cells were pelleted
at 8000 g for 10 minutes at 4°C and stored at –20°C until required.
Cell pellets were resuspended in STE buffer, pH 8.0 (150 mM Tris
pH 8.0, 150 mM NaCl, 5 mM EDTA, 5 mM DTT), plus 100 µg/ml
lysozyme and 5 mM DTT. Bacterial suspensions were lysed by
sonication and N-lauroylsarcosyl was added to a final concentration
of 1.5% and proteins were extracted for 30 minutes at 4°C. Insoluble
material was removed by centrifugation at 14,000 g for 20 minutes.
Triton X-100 (1% final concentration) was added to the soluble
fraction and this was subjected to affinity chromatography using
glutathione-Sepharose 4B (Amersham Bioscience, Sweden)
according to the manufacturer’s instructions. Bound fusion proteins
were eluted from the matrix with 10 mM glutathione in column buffer
(50 mM Tris pH 8.0, 150 NaCl, 5 mM DTT) with 1% Triton X-100.
Finally, purified fusion proteins were desalted on a PD10 column
(Pharmacia Biotech) and fraction aliquots stored at –70°C until use.
Liposome binding assays
L-3-phosphatidyl[N-methyl-3H]choline 1,2-dipamitoyl (85 Ci/mmol)
was obtained from Amersham. Phosphatidylcholine (PC),
phosphatidylethanolamine (PE) and phosphatidylserine (PS) were
obtained from Sigma (USA). Phosphatidylinositol 3-phosphate
[PtdIns(3)P], phosphatidylinositol 3,4-bisphosphate [PtdIns(3,4)P2],
phosphatidylinositol 3,5-bisphosphate [PtdIns(3,5)P2],
phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3] were
obtained from Echelon (Salt Lake City, USA). Liposome binding
assay was performed as follows and as described (Gaullier et al.,
2000). Liposomes were prepared at 0.35 mg/ml containing 63-65%
PC, 20% PS, 15% PE, 2% phosphatidylinositol (PI) and a trace of
[3H]PC, suspended in liposome buffer (20 mM Tris-HCl, pH 7.5, 60
mM NaCl), and sonicated on ice. GST fusion proteins were desalted
into the liposome buffer and 20 µg GST or a molar equivalent of GST-
SNX5PX or GST-Hrs fusion proteins immobilized on 50 µl of 50%
(v/v) glutathione-Sepharose beads by rotation for 30 minutes at room
temperature. The beads were washed three times and resuspended in
100 µl liposome buffer. 100 µl sonicated 3H-labelled liposomes were
added and the mixture incubated for 30 minutes with gentle rotation
at room temperature. The beads were washed twice in liposome
buffer, the supernatants collected and radioactivity determined. The
percentage of 3H-labelled liposomes bound to the Sepharose beads
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was calculated as follows: [c.p.m. in pellet/total c.p.m. (test beads)] –
[c.p.m. in pellet/total c.p.m. (beads alone)]. All experiments were
carried out in triplicate.
Yeast two-hybrid analysis
Saccharomyces cerevisiae EGY48 (a-trp, ura3-52, his3, leu2), the
pYESTrp and pLexA expression vectors were obtained from Clontech
and yeast two-hybrid analysis performed using the standard protocol
supplied by the manufacturer. The full-length cDNAs for SNX1,
SNX5 and hVps35 were subcloned into both of the yeast expression
vectors and transformed into EGY48. Each expression construct was
initially assayed, using the liquid β-galactosidase assay, for
autoactivation of the reporter gene and constructs that displayed levels
of autoactivation above that of the empty vector were not used. Six
independent colonies transformed with the expression plasmids were
assayed to reduce the impact of clonal variation. The expression of
the full-length fusion protein product was confirmed by
immunoblotting of whole cell extracts.
Results
SNX5 PX domain is localized to a similar endosomal
compartment as full-length SNX5
SNX5 is a 404-residue hydrophilic protein that contains a
central PX domain and two coiled-coil regions within the large
C-terminal domain (Teasdale et al., 2001). The full-length
SNX5 molecule was epitope tagged with FLAG (FLAG-
SNX5FL), and in transfected HeLa cells was associated with
punctate cytoplasmic structures indicative of endosomes (Fig.
1). The PX domains of some proteins have been shown to be
sufficient for targeting to intracellular membranes. To
determine if the PX domain of SNX5 can be independently
recruited to endosomes via PI binding, we generated a
construct containing the PX domain (residues 64-166) of
SNX5 fused to GFP. After 12 hours of transfection, GFP-
SNX5PX fusion protein was detected on endosomal-type
structures dispersed throughout the cytoplasm (Fig. 1).
Approximately 80% of transfected cells showed a punctate
staining pattern similar to that depicted in Fig. 1 whereas the
remaining 20% of transfected cells showed a low level of
cytoplasmic staining. Furthermore, in cells co-transfected
with GFP-SNX5PX and FLAG-tagged full-length SNX5,
substantial colocalization of GFP-SNX5PX fusion protein with
the FLAG-SNX5FL was observed (Fig. 1). The cytoplasmic
staining patterns in cells co-transfected with both constructs
was similar to the individual constructs alone (not shown).
Therefore, these results indicate that the localization of the PX
domain of SNX5 reflects the specific localization of the full-
length molecule.
One possibility for the colocalization of the individual SNX
domains with FLAG-SNX5FL is that the two molecules may
associate physically. To determine if SNX5PX can form
oligomers with full-length SNX5, HeLa cells were transfected
with expression vectors encoding both GFP-SNX5PX and
FLAG-SNX5FL and extracts of transfected cells were
immunoprecipitated with antibodies either to the FLAG
epitope or to GFP. The immunoprecipitates were
immunoblotted and no association was detected between GFP-
SNX5PX and FLAG-SNX5FL (not shown). Although the
disruption of an interaction between GFP-SNX5PX and FLAG-
SNX5FL during solubilization cannot be excluded, these results
indicate that the localization studies above reflect independent
targeting of GFP-SNX5PX molecules to endosomal structures.
To identify the GFP-SNX5PX-positive structures, transfected
HeLa cells were labelled with antibodies to various markers.
Only very modest levels of colocalization were observed
between the GFP-SNX5PX fusion protein and either the early
endosome marker EEA1 or the late endosome marker LAMP1
(Fig. 2A,B). Furthermore, very little colocalization was
detected between GFP-SNX5PX and endogenous SNX1 (Fig.
2A). By contrast, and as expected, endogenous SNX1 shows
considerable colocalization with EEA1 (Fig. 2B). These results
indicate that the PX domain of SNX5 may be recruited to a
membrane domain distinct from the PX domain of SNX1.
To further define the localization of SNX5, and to ensure that
overexpression of constructs had not influenced the intracellular
location of the SNX5 products, we generated stable HEK293
cells expressing full-length SNX5 fused to GFP. The use of the
Flp-InTM system ensured equivalent levels of expression within
the cell population. The GFP fusion protein was localized on
endosomal structures as well as being distributed in the
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Fig. 1. SNX5 PX domain
colocalizes with the full-
length SNX5 protein.
HeLa cells were co-
transfected with the full-
length SNX5 protein
(FLAG-SNX5FL) and a
construct of SNX5
containing the PX
domain (GFP-SNX5PX).
After 12 hours of
transfection, cells were
fixed, permeabilized and
stained with anti-FLAG
monoclonal antibody
followed by goat anti-
mouse IgG-Alexa568
conjugate. Confocal
images were collected
with identical iris
settings. Superimposed
images (Merge) reveal
regions of colocalization.
Plasma membrane
staining is due to non-
specific staining with the
anti-FLAG monoclonal
antibody. Bar, 10 µm.
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cytoplasm of stable HEK293 cells, consistent with the results
observed in transiently transfected HeLa cells (Fig. 3A). Only
a low level of colocalization of GFP-SNX5 and EEA1 was
observed (Fig. 3A shows a representative example) again
consistent with the localization of SNX5 constructs in
transiently transfected HeLa cells. However, GFP-SNX5-
labelled structures were frequently found closely juxtaposed to
EEA1 stained structures (Fig. 3A), suggesting that SNX5 was
localized to a region of the early endosomes distinct from
EEA1. Often, GFP-SNX5 was associated with enlarged
endocytic structures, with profiles typical of enlarged early
endosomes that have been described as a consequence of the
expression of components of the endocytic machinery, such as
rab5 mutants (Stenmark et al., 1994; Chen and Wang, 2001;
Gillooly et al., 2003). These GFP-SNX5-positive enlarged
Fig. 3. Localization of GFP-SNX5FL fusion protein in
stably transfected HEK293 cells. (A) HEK293 cells stably
expressing a GFP-SNX5FL fusion protein were fixed in
4% paraformaldehyde, permeabilized with 0.1% Triton-X-
100, and co-stained for EEA1 with human anti-EEA1
antibodies followed by human anti-Ig Alexa568. (B) High
power image showing enlarged GFP-SNX5FL-positive structures that
also stain for EEA1. Note the lack of colocalization of the two
molecules within these structures. Confocal images were collected
with identical iris settings. Superimposed images (Merge) reveal
regions of colocalization. Bar, 10 µm (A) and 5 µm (B).
Fig. 2. Intracellular localization of human SNX5 PX domain in transfected
HeLa cells. (A) HeLa cells were transiently transfected with GFP-SNX5PX and
after 12 hours of transfection, cells were fixed in 4% paraformaldehyde,
permeabilized with 0.1% Triton-X-100, and co-stained for EEA1, Lamp-1 and
SNX1. EEA1 was detected with human anti-EEA1 antibodies followed by
human anti-Ig Alexa568, and Lamp-1 and SNX1 were detected with mouse
monoclonal antibodies and goat anti-mouse IgG-Alexa568 conjugate. (B) EEA1
was detected with human anti-EEA1 antibodies and FITC-goat anti-human IgG
and SNX1 as for A. Control incubations demonstrated no cross-reactivity
between the anti-Ig conjugates and the irrelevant primary antibody. Confocal
images were collected with identical iris settings. Superimposed images (Merge)
reveal regions of colocalization. Inserts show regions of the cell at higher
magnification. Bar, 10 µm.
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structures were also positively labelled for EEA1, however,
GFP-SNX5 was often found on regions distinct from EEA1
(Fig. 3B).
The location of GFP-SNX5 within the endocytic pathway
was further investigated by co-staining experiments with
an endocytic fluid-phase marker. Texas-Red dextran was
incubated with the stable HEK293 cells for 10 minutes at 37°C
to allow fluid-phase uptake in endocytic compartments. GFP-
SNX5 showed extensive colocalization with the endosomal
compartments defined by the fluid-phase marker (Fig. 4). In
addition, often distinct regions of the same structures were
labelled with either GFP-SNX5 or Texas Red dextran
suggesting that SNX5 may be located in membrane regions of
the early endosome with a low luminal volume.
It has recently been shown that SNX1 can physically interact
with the retromer component, Vps35p using a yeast two-hybrid
assay (Haft et al., 2000). In view of the distinct endosomal
locations of SNX1 and SNX5 we have compared their ability
to interact with retromer. To determine if SNX5 also interacts
with Vps35p we also used the yeast two-hybrid assay. As
expected SNX1 showed a strong interaction with Vps35p,
whereas SNX5 did not interact with Vps35 in this assay (not
shown). This result demonstrates differences in protein-protein
interactions of these two SNX molecules that may play an
important role in their recruitment to specific membranes and
their function.
Membrane binding of PX domain is inhibited by
wortmannin
To determine if the binding of the GFP-SNX5PX to endosomes
was dependent on lipid, transfected cells were treated with the
PI 3-kinase inhibitor wortmannin. The addition of wortmannin
(100 nM) resulted in the dissociation of the GFP-SNX5PX
fusion protein from endosomal structures, and the appearance
of weak fluorescence dispersed throughout the cytoplasm (Fig.
5). Analysis of transfected cells treated with wortmannin
showed that approximately 80% of treated cells displayed
exclusively cytosolic fluorescence whereas the remaining 20%
of cells still displayed endosomal staining. The dissociation of
GFP-SNX5PX from endosomes in the presence of wortmannin
clearly shows a phosphoinositide-dependent binding of
SNX5PX to this endosomal compartment
The lipid dependence of the endosomally localized GFP-
SNX5 in the stable HEK293 cells was also assessed. Within
20 minutes of treatment with 100 nM wortmannin, the GFP-
SNX5 fusion protein was found exclusively in the cytosol of
the entire cell population, demonstrating the importance of
PtdIns(3)P binding to the localization of the full-length
molecule (Fig. 5B).
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Fig. 4. Colocalization of
GFP-SNX5FL fusion
protein in HEK293 cells
with the fluid-phase
marker, Texas-Red dextran.
HEK293 cells stably
expressing the GFP-
SNX5FL fusion protein
were incubated in Texas-
Red dextran (100-200
µg/ml) for 15 minutes at
37°C as described in
Materials and Methods.
Cells were fixed in 4%
paraformaldehyde.
Confocal images were
collected with identical iris
settings. Superimposed
images (Merge) reveal
regions of colocalization.
Inserts show regions of the
cell at higher
magnification. Bar, 10 µm.
Fig. 5. Endosomal localization of PX domain of SNX5 requires the
activity of a wortmannin sensitive PI 3-kinase. (A) HeLa cells were
transfected with GFP-SNX5PX, and after 12 hours cell monolayers
were serum-starved for 3 hours. Cells were either untreated or treated
with 100 nM wortmannin for 2 hours at 37°C and fixed in 4%
paraformaldehyde. (B) HEK293 cells expressing GFP-SNX5FL were
either untreated or treated with 100 nM wortmannin for 20 minutes
at 37°C and fixed in 4% paraformaldehyde. Bar, 10 µm.
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SNX5 is localized within PtdIns(3)P microdomains
To determine the relationship of PtdIns(3)P and SNX5
localization, we transfected HeLa cells with both FLAG-
SNX5FL and GFP-FYVEEEA1, a probe for PtdIns(3)P.
Significantly, both SNX5 and the FYVE construct showed
considerable colocalization, demonstrating that SNX5 is
indeed localized to the early endosomes and, in particular, to
PtdIns(3)P-containing membrane domains (Fig. 6A). However,
SNX5 and the FYVE construct showed only partial
colocalization, a result that indicates the presence of
PtdIns(3)P sub-domains devoid of SNX5. As expected GFP-
FYVEEEA1 also showed considerable overlap with EEA1 (Fig.
6B), consistent with previous findings (Gillooly et al., 2003).
PX domain of SNX5 binds to PtdIns(3)P and
PtdIns(3,5)P2
There is limited information on the precise phosphoinositide
binding specificity of the PX domains of the different SNX
molecules. Given the recent finding that SNX1 binds to both
PtdIns(3)P and PtdIns(3,5)P2 (Cozier et al., 2002), it is
important to ascertain if the PX domains of different SNX
family members have the same or a different phosphoinositide
binding specificity as SNX1. This is particularly relevant as
SNX5PX shows very little endosomal colocalization with
SNX1 or EEA1. We used the physiologically relevant
liposome-binding assay to examine the phosphoinositide
specificity of SNX5. A GST fusion protein was constructed
with the PX domain of SNX5. Liposomes generated
were composed of a mixture of phosphatidylserine,
Fig. 6. SNX5 partially colocalizes with the PtdIns(3)P probe, GFP-
FYVEEEA1. (A) HeLa cells were transfected with FLAG-SNX5FL and
GFP-FYVEEEA1. After 24 hours, cell monolayers were permeabilized
and stained with anti-FLAG monoclonal antibody followed by goat
anti-mouse IgG-Alexa568 conjugate. (B) HeLa cells transfected with
GFP-FYVEEEA1 as above and stained for EEA1 with mouse anti-
EEA1 antibodies followed by anti-Ig Alexa568. Confocal images
were collected with identical iris settings. Superimposed images
(Merge) reveal regions of colocalization. Bar, 10 µm.
Fig. 7. The PX domain of SNX5 binds to PtdIns(3)P and
PtdIns(3,4)P2. The ability of SNX5PX domain to bind different
phosphoinositides was analysed using a liposome binding assay. 3H-
labelled liposomes were prepared as described containing either
PtdIns(3)P, PtdIns(3,4)P2, PtdIns(3,5)P2, PtdIns(3,4,5)P3 or no PI, as
indicated. Sonicated liposomes (100 µl) were incubated for 30
minutes at room temperature with 20 µg GST or purified GST-
SNX5PX fusion protein immobilized on glutathione-Sepharose beads.
After incubation, the beads were washed three times and collected by
centrifugation. The radioactivity in both pellets and supernatant was
determined. The assay was performed in triplicate and the standard
deviations are shown.
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phosphadtidylethanolamine and phosphatidylcholine to which
was added either PtdIns(3)P, PtdIns(3,4)P2, PtdIns(3,5)P2 or
PtdIns(3,4,5)P3. Under these assay conditions, the FVYE
finger domains of Hrs showed strong binding to PtdIns(3)P-
containing liposomes, but not to the others, consistent with
published data (not shown) (Gaullier et al., 1998). Using this
liposome binding assay, the PX domain of SNX5 binds to
PtdIns(3)P and PtdIns(3,4)P2 with very little specific binding
detected to the other phosphoinositides
(Fig. 7), a specificity that distinguishes
this PX domain from the PX domain of
SNX1. Fig. 7 shows a representative
assay of four separate liposome-binding
experiments.
SNX5 is recruited to the cell surface
following EGF stimulation
As PtdIns(3,4)P2 is predominantly found
on the cytosolic face of the plasma
membrane (Gray et al., 1999; Oatey et al.,
1999), we investigated whether the
PtdIns(3,4)P2 binding by SNX5 detected
in the in vitro assay was biologically
relevant. The levels of plasma membrane
PtdIns(3,4)P2 are regulated by
extracellular signals such as EGF,
therefore, we investigated whether the
intracellular location of SNX5 may be
influenced by increases of this
phosphoinositide intermediate following
receptor stimulation. GFP-SNX5PX-
transfected HeLa cells were stimulated
with EGF and the location of the GFP-
SNX5PX fusion protein analysed over a
period of 30 minutes (Fig. 8). Prior to
stimulation, the fusion protein was found
on endosomes structures in the majority
of transfected cells (>80%). Within 5
minutes of EGF stimulation, GFP-
SNX5PX was found within the cytosol and
on patches on the plasma membrane (Fig.
8). Analysis of 50 transfected cells
showed that more than 60% of GFP-
positive cells had both cytosolic and
plasma membrane staining. Very little
endosomal staining by GFP-SNX5PX was
observed in the transfected cells at either
5 or 10 minutes after EGF stimulation.
The cellular distribution of the EGF
receptors was also determined. Within 10
minutes of stimulation, EGF receptors
had been internalized from the cell
surface and were localized to intracellular
endosomes (not shown); therefore, the
generation of PtdIns(3,4)P2 at the plasma
membrane would be expected to be
maximal by 5-10 minutes after EGF
stimulation. By 20 minutes following
receptor activation, the level of GFP-
SNX5PX plasma membrane and cytosolic
staining had receded and an endosomal
location was now apparent (Fig. 8). By 30
minutes, the localization of GFP-SNX5PX
had returned to an endosomal distribution
Journal of Cell Science 117 (26)
Fig. 8. SNX5 associates with the plasma membrane following EGF stimulation of
transfected HeLa cells. HeLa cells were transfected with constructs encoding GFP-SNX5PX
or GFP-SNX5FL. Untransfected HeLa cells were also grown under the same conditions.
After 12 hours, cell monolayers were serum-starved for 3 h and either left unstimulated or
stimulated with human EGF (100 ng/ml) for the indicated times, fixed and processed for
fluorescence. The distribution of GFP-SNX5PX and GFP-SNX5FL was directly visualized by
confocal microscopy. Untransfected cells were stained with anti-SNX1 monoclonal
antibody followed by goat-anti-mouse IgG conjugated to Alexa568. Bar, 10 µm.
6421Membrane recruitment of SNX5
similar to that observed prior to stimulation with EGF. The
time-course of the transient relocation of GFP-SNX5PX to the
plasma membrane following EGF stimulation parallels the
increase in levels of plasma membrane PtdIns(3,4)P2 in other
systems
. 
For example, previous reports have indicated that
PtdIns(3,4)P2 levels increase within 2-10 minutes of
stimulation by growth factors and return to basal levels by 20
minutes (Kimber et al., 2002). This dramatic redistribution of
the PX domain of SNX5 following EGF stimulation has been
observed in three separate experiments.
To determine whether the dynamic movement of GFP-
SNX5PX reflected the behaviour of the full-length SNX5
molecule following EGF stimulation, the experiment was
repeated using HeLa cells transfected with GFP-SNX5FL. After
10 minutes of EGF stimulation the full-length SNX5 was found
predominantly within the cytosol and also associated with
regions of the plasma membrane (in more than 60% of
transfected cells). As for the SNX5 PX domain, after 20
minutes of EGF stimulation, most of the full-length SNX5 was
found again associated with endosomes (Fig. 8).
The localization of full-length SNX5 in stable HEK293 cells
expressing GFP-SNX5 was also affected by EGF treatment.
Within 3 minutes of EGF treatment SNX5 was readily detected
at the plasma membrane and staining was very prominent by
12 minutes, and by 20 minutes the cell surface recruitment of
SNX5 had disappeared (Fig. 9). The stable cell line maintained
considerable endosomal staining throughout the EGF treatment
period indicating that the recruitment of SNX5 to the plasma
membrane may be mediated via the cytosol pool of SNX5.
These results show that the recruitment of SNX5 to the plasma
membrane can occur in different cell types.
In contrast to the movement of the SNX5-PX domain or the
full-length SNX5 molecule, endogenous SNX1, which does
not bind to PtdIns(3,4)P2, showed no change in the intracellular
endosomal location following EGF stimulation in either
transiently transfected HeLa cells (Fig. 8) or stable HEK293
transfectants (not shown). Collectively these data suggest that
the transient movement of SNX5 to the plasma membrane
following EGF receptor stimulation is mediated by the ability
of the PX domain of SNX5 to bind PtdIns(3,4)P2.
Discussion
Members of the sorting nexin family have been implicated in
the regulation of the trafficking of internalized receptors (Barr
et al., 2000; Cozier et al., 2002; Stockinger et al., 2002; Hanson
and Hong, 2003). In this study, we have analysed the
localization and behaviour of SNX5, a sorting nexin with a PX
domain and two coiled-coil regions. Based on structural and
sequence relationships, SNX5 is closely related to SNX1, -2,
-4 and -6 (Teasdale et al., 2001). However, the localization and
behaviour of SNX5 differs from other sorting nexins
characterized to date. First, SNX5 was localized to an early
endosomal domain in non-stimulated cells distinct from a
number of other markers of the early endosomes; second, the
PX domain was able to independently target a GFP fusion to
similar endosomal structures as the full-length molecule; third,
unlike SNX1, SNX5 cannot interact with the retromer
component Vps35p; fourth, the PX domain of SNX5 binds
selectively to not only PtdIns(3)P but also PtdIns(3,4)P2; and
fifth, this dual PI binding specificity is associated with transient
location of SNX5 to the cell surface following EGF
stimulation. The ability of a sorting nexin to be recruited to the
plasma membrane following a transient increase in
phosphoinositide second messenger levels is novel and
potentially broadens the functions of the family of SNX
molecules. Furthermore, the regulated translocation of SNX5
to the cell surface, a process possibly mediated by PX domain-
Fig. 9. SNX5 associates
with the plasma
membrane following
EGF stimulation of
HEK293 cells expressing
GFP-SNX5FL. Stable
HEK293 cells stably
expressing GFP-SNX5FL
were serum-starved for 3
h and either left
unstimulated or
stimulated with human
EGF (20 ng/ml) for the
indicated times, fixed
and processed for
fluorescence. Bar,
10 µm.
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lipid interactions, is likely to be crucial to the proper
functioning of SNX5.
Numerous PX domains, including those from sorting nexins,
have been shown to bind specifically to phosphoinositides with
the majority interacting selectively with PtdIns(3)P (Xu et al.,
2001a; Yu and Lemmon, 2001; Lemmon, 2003). Consistent
with these earlier studies we have shown here that the isolated
PX domain of SNX5 binds PtdIns(3)P. However, in addition
to PtdIns(3)P the SNX5-PX domain also binds to
PtdIns(3,4)P2. The PI binding specificity of SNX5-PX domain
contrasts with SNX1, which binds selectively to PtdIns(3)P
and PtdIns(3,5)P2 based on the liposome binding assay (Cozier
et al., 2002), whereas SNX3 appears to interact exclusively
with PtdIns(3)P. SNX16 binds predominantly to PtdIns(3)P,
although the isolated SNX16 PX domain also shows very weak
binding to PtdIns(3,4)P2 based on protein-lipid overlays
(Hanson and Hong, 2003). From these studies, it is clear that
there are differences in the PI binding specificities of different
sorting nexins. Detailed analyses of other SNX-PX domains
are now warranted. Sequence comparison between the PX
domains shows some interesting features of the SNX5-PX
domain that may account for its unusual PI binding specificity.
In particular, the SNX5-PX domain has an insert between the
Pro-rich sequence and the α3 helix of the PX structure
(Teasdale et al., 2001; Worby and Dixon, 2002). In addition,
the highly conserved Arg58 and Arg105 of the p40phox domain,
basic residues that interact directly with PtdIns(3)P, are
replaced in SNX5-PX by Gln and Thr residues, respectively
(Bravo et al., 2001). SNX6, which shares 66% sequence
identity to SNX5, also contains an insert in the PX domain.
Clearly, it will be interesting to resolve the structural basis for
the PI binding specificity of SNX5-PX. 
The PX domain of SNX5 was localized to endosomal
structures in transfected cells and the inhibition of membrane
binding by wortmannin demonstrates the importance of PI 3-
kinase activity in the membrane localization of SNX5-PX.
Several PX domains when expressed in isolation are known to
efficiently target PtdIns(3)P-containing membranes in vivo
(Kanai et al., 2001), including SNX3 (Xu et al., 2001a). In
other cases, such as SNX1, endosomal targeting requires both
the PX domain and the C-terminal coiled coil regions (Teasdale
et al., 2001; Zhong et al., 2002). The ability of SNX5-PX to
target membranes in vivo indicates that this PX domain binds
strongly to PtdIns(3)P. As the SNX5-PX domain colocalized
with full-length SNX5, the membrane targeting of the isolated
PX domain clearly reflects the full-length protein.
The intracellular distribution of SNX5 was subtly different
to EEA1 and SNX1. Although colocalization with EEA1 was
occasionally observed, careful quantitative analyses showed
that in the majority of transfected cells there was very little
direct overlap between either EEA1 or SNX1 and SNX5. The
colocalization with the fluid-phase marker Texas-Red dextran,
the extensive colocalization with the PtdIns(3)P probe, GFP-
FYVEEEA1, the inhibition of membrane binding by the PI
3-kinase inhibitor wortmannin, together with the physical
proximity of the individual EEA1 and SNX5 decorated
structures, strongly indicates that SNX5 is localized to a
PtdIns(3)P subdomain of early endosomes. A recent study has
also demonstrated that different PtdIns(3)P binding proteins
differ in their microdomain distribution, in particular EEA1
and Hrs (Gillooly et al., 2003) and our results extend these
observations to include sorting nexins. The localization of the
SNX5 constructs to a different PtdIns(3)P subdomain from
EEA1 may be due to interactions with both lipid and protein.
Alternatively, the context in which the PtdIns(3)P lipid is
presented within the membrane may differ between
microdomains and limit the recruitment of the different
PtdIns(3)P binding proteins to specific domains.
The endosomal localization of SNX5 also differs from other
sorting nexins characterized to date. For example, many sorting
nexins of the SNX1 subfamily show partial colocalization with
early endosome markers, which is perhaps not surprising as
SNX1, SNX2, SNX3 and SNX4 have been found to interact
with each other and form heterooligomers (Haft et al., 1998).
SNX15 and SNX16 show partial overlap with the late
endosomal marker LAMP1 (Barr et al., 2000; Hanson and
Hong, 2003), and the yeast t-SNARE Vam7 localizes to
vacuole membranes (Cheever et al., 2001).
The C-terminal domain of SNX5 contains coiled-coil
regions and is likely to be involved in multiprotein complexes.
Previously, we showed that the C-terminal domain of SNX5
(residues 167-404) was localized to endosomal structure
(Seaman et al., 1998; Teasdale et al., 2001), indicating the
possible involvement of protein-protein interactions of the
membrane-associated full-length molecule. Significantly,
SNX1 sub-group molecules, SNX1, SNX2 and Vps5p have
been identified to be part of a membrane-associated complex,
termed the retromer, which contains Vps26p, Vps29p and
Vps35p (Haft et al., 2000). First identified in yeast and now in
mammalian cells, the retromer is considered to function as a
membrane coat complex for vesicular transport (Seaman et al.,
1998; Haft et al., 2000). The mammalian retromer is probably
involved in one or more of the endosomal transport pathways.
Our finding that SNX5 cannot interact with Vps35p, further
distinguishes this sorting nexin from SNX1, and indicates that
SNX5 does not interact with retromer components but rather
may function in a different complex. SNX5 has been reported
to bind the Fanconi anaemia complementation group A
protein, detected in a yeast two-hybrid screen and by co-
immunoprecipitation experiments (Otsuki et al., 1999).
However, the significance of this interaction remains unclear.
PtdIns(3,4)P2 is present at very low levels in non-stimulated
cells but its concentration, along with PtdIns(3,4,5)P3,
increases dramatically at the plasma membrane after receptor
stimulation (Gray et al., 1999; Oatey et al., 1999;
Vanhaesebroeck et al., 2001). Based on the liposome binding
assay, the PX domain of SNX5 recognizes PtdIns(3,4)P2 but
not PtdIns(3,4,5)P3. Many proteins with the phosphoinositol
recognition pleckstrin homology (PH) domains bind to either
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 or to PtdIns(3,4,5)P3 only
(Lemmon, 2003). The PX domain of p47phox appears to bind
selectively to PtdIns(3,4)P2, which is likely to account for the
movement of the phagocyte NADPH oxidase to the plasma
membrane after neutrophil stimulation and phagocytosis
(Kanai et al., 2001). The SNX5-PX domain is unusual amongst
PI binding domains in recognizing both PtdIns(3)P and
PtdIns(3,4)P2. The binding of the SNX5-PX domain to the
plasma membrane of stimulated cells is probably due to a
direct interaction with PtdIns(3,4)P2 as first, the transient
interaction with the plasma membrane is consistent with the
transient wave of PtdIns(3,4)P2 production (Kimber et al.,
2002); second, the PX domain used in our studies represents
Journal of Cell Science 117 (26)
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the minimal PX domain sequence and does not contain other
domains; and third, the ability of SNX5 to bind to the plasma
membrane is specific, as SNX1, which does not bind to
PtdIns(3,4)P2 or PtdIns(3,4,5)P3 (Cozier et al., 2002) is not
recruited to the plasma membrane after cell stimulation.
Furthermore, we have demonstrated colocalization of SNX5
with actin-rich regions of the plasma membrane (our
unpublished observations), consistent with the central role of
PI-signalling molecules in the regulation of cytoskeletal-
membrane linkages (Vanhaesebroeck et al., 2001). Thus the
behaviour of SNX5 is more typical of PH domain proteins that
respond to elevated second messenger molecules at the cell
surface. Of interest is the recent finding that the signalling
enzyme phospholipase D1 recycles between endosomes and
the plasma membrane by coordinating interactions mediated
by PI-binding PH and PX domains (Du et al., 2003). In view
of these findings, the possibility that other sorting nexins may
be able to traffic between distinct membrane compartments
should be considered.
The production of PtdIns(3,4)P2 or PtdIns(3,4,5)P3, detected
at the plasma membrane, is a key event during cell signalling
as it allows the recruitment of proteins with PH domains which
control the activity and subcellular localization of an array of
signal transduction molecules (Lemmon and Ferguson, 2000).
Attention has primarily focused on PtdIns(3,4,5)P3 as it
represents the major product of ligand-stimulated PI 3-kinases
(Rameh and Cantley, 1999). The majority of PtdIns(3,4)P2 is
considered to be derived from phosphatase action on
PtdIns(3,4,5)P3, although recent data has suggested that
PtdIns(3,4)P2 can be synthesized independently of
PtdIns(3,4,5)P3 (Banfic et al., 1998a; Banfic et al., 1998b). The
recent identification of a PH domain, from the protein TAPP1,
which interacts selectively with PtdIns(3,4)P2 (Kimber et al.,
2002) indicates the possibility of PtdIns(3,4)P2-specific
signalling pathway. Our findings here on SNX5 raise the
possibility that this sorting nexin is targeting a complex to the
site of plasma membrane signalling. Using the TAPP1 PH
domain as a probe for immunoelectron microscopic labelling,
PtdIns(3,4)P2 was not only detected at the plasma membrane
of stimulated cells but also on intracellular membranes such as
multivesicular endosomes (Watt et al., 2004), raising the
possibility that the PtdIns(3,4)P2 binding properties of SNX5
may impact on its intracellular localization.
In summary, SNX5 is recruited to a subdomain of the early
endosome distinct from EEA1 and SNX1, and the PI binding
PX domain plays a dominant role in its localization. It is
likely that the SNX5-specific domain is associated with a role
in protein sorting within the early endosome. In addition to
an endosomal localization, SNX5 can shuttle from the
cytoplasm to the plasma membrane as a consequence of EGF
signalling. The localization of SNX5 to the plasma membrane
is likely to be mediated by the binding of the PX domain to
PtdIns(3,4)P2, although interactions with proteins may also
be involved. Although the function of SNX5 recruitment to
the plasma membrane is not known, the behaviour of SNX5
reinforces the dynamic interplay between components of the
endosome machinery and signalling events. Sorting nexins
represent a very large family, and the results here highlight
the need to examine closely the localization of individual
sorting nexins not only in quiescent cells but also under a
variety of stimuli.
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